추가 설명:
A biopharmaceutical anemia treatment supplying recombinant human erythropoietin in 2,000 IU, 4,000 IU, and 10,000 IU prefilled syringes. Indications include anemia associated with chronic renal failure in dialysis patients, symptomatic renal anemia in patients not yet on dialysis, and prevention of anemia in infants and adults, including increasing yield of autologous blood donations.
평가 & 댓글 남기기